Online citations, reference lists, and bibliographies.

Phosphodiesterases And Cyclic Nucleotide Signaling In The CNS

M. Conti, W. Richter
Published 2014 · Chemistry

Cite This
Download PDF
Analyze on Scholarcy
Share
This paper references
10.1177/002215540004800512
Immunohistochemical Localization of cGMP-binding cGMP-specific Phosphodiesterase (PDE5) in Rat Tissues
J. Kotera (2000)
10.1016/S0006-8993(03)02754-9
Immunohistochemical localization of PDE10A in the rat brain
Thomas Francis Seeger (2003)
10.1046/J.1432-1327.2001.01866.X
Genomic organization of the human phosphodiesterase PDE11A gene
K. Yuasa (2001)
10.1002/SYN.1043
Differential distribution of cAMP-specific phosphodiesterase 7A mRNA in rat brain and peripheral organs.
X. Miró (2001)
10.1046/j.1471-4159.2002.00878.x
Regulation of cAMP‐specific phosphodiesterases type 4B and 4D (PDE4) splice variants by cAMP signaling in primary cortical neurons
C. D'Sa (2002)
10.1042/BJ20040846
PKA-phosphorylation of PDE4D3 facilitates recruitment of the mAKAP signalling complex.
Jennifer J Carlisle Michel (2004)
10.1016/0028-3908(83)90239-3
Potential antidepressant activity of rolipram and other selective cyclic adenosine 3′,5′-monophosphate phosphodiesterase inhibitors
Helmut Wachtel (1983)
Fractionation and characterization of a cyclic adenine ribonucleotide formed by tissue particles.
E. Sutherland (1958)
10.1007/s00213-004-1967-7
Dissociable effects of acetylcholinesterase inhibitors and phosphodiesterase type 5 inhibitors on object recognition memory: acquisition versus consolidation
J. Prickaerts (2004)
10.1523/JNEUROSCI.0864-09.2009
Phosphodiesterase 5 Inhibition Improves Synaptic Function, Memory, and Amyloid-β Load in an Alzheimer's Disease Mouse Model
D. Puzzo (2009)
10.1016/j.brainres.2006.04.032
Regulation of phosphodiesterase-4 (PDE4) expression in mouse brain by repeated antidepressant treatment: Comparison with rolipram
D. Dlaboga (2006)
10.1001/ARCHNEUR.64.3.456
Changes in PDE4D isoforms in the hippocampus of a patient with advanced Alzheimer disease.
C. McLachlan (2007)
10.1002/SYN.20459
Differential distribution of PDE4B splice variant mRNAs in rat brain and the effects of systemic administration of LPS in their expression.
Elisabet Reyes-Irisarri (2008)
10.1523/JNEUROSCI.22-12-05188.2002
Phosphodiesterase 1B Knock-Out Mice Exhibit Exaggerated Locomotor Hyperactivity and DARPP-32 Phosphorylation in Response to Dopamine Agonists and Display Impaired Spatial Learning
T. Reed (2002)
10.1021/BI047313H
Structural determinants for inhibitor specificity and selectivity in PDE2A using the wheat germ in vitro translation system.
A. Iffland (2005)
10.1523/JNEUROSCI.1635-10.2010
Interplay of Palmitoylation and Phosphorylation in the Trafficking and Localization of Phosphodiesterase 10A: Implications for the Treatment of Schizophrenia
Erik I. Charych (2010)
10.1073/pnas.85.8.2424
cGMP phosphodiesterase of retinal rods is regulated by two inhibitory subunits.
P. Deterre (1988)
10.1038/nrd2058
Phosphodiesterases in the CNS: targets for drug development
F. Menniti (2006)
10.1073/pnas.73.5.1684
dunce, a mutant of Drosophila deficient in learning.
Y. Dudai (1976)
10.1002/cne.10955
mRNA expression patterns of the cGMP‐hydrolyzing phosphodiesterases types 2, 5, and 9 during development of the rat brain
W. C. V. van Staveren (2003)
10.1097/YPG.0b013e3283060fb8
Phosphodiesterase-4A expression is reduced in cerebella of patients with bipolar disorder
S. Fatemi (2008)
10.1124/jpet.110.173294
Chronic Suppression of Phosphodiesterase 10A Alters Striatal Expression of Genes Responsible for Neurotransmitter Synthesis, Neurotransmission, and Signaling Pathways Implicated in Huntington's Disease
R. Kleiman (2011)
10.1124/jpet.107.132910
Preclinical Characterization of Selective Phosphodiesterase 10A Inhibitors: A New Therapeutic Approach to the Treatment of Schizophrenia
C. Schmidt (2008)
Identification of the phosphorylation site in vitro for cAMP-dependent protein kinase on the rat adipocyte cGMP-inhibited cAMP phosphodiesterase.
A. Rascón (1994)
10.1016/j.ejphar.2008.10.027
Phosphodiesterase 2 and 5 inhibition attenuates the object memory deficit induced by acute tryptophan depletion.
Eva L. van Donkelaar (2008)
10.1124/MOL.53.1.23
Characterization of the rolipram-sensitive, cyclic AMP-specific phosphodiesterases: identification and differential expression of immunologically distinct forms in the rat brain.
S. Iona (1998)
10.1074/jbc.M303269200
Attenuation of the Activity of the cAMP-specific Phosphodiesterase PDE4A5 by Interaction with the Immunophilin XAP2*
G. Bolger (2003)
10.1038/sj.mp.4002048
A whole genome association study of neuroticism using DNA pooling
S. Shifman (2008)
10.1074/JBC.M001734200
Membrane Localization of Cyclic Nucleotide Phosphodiesterase 3 (PDE3)
Y. Shakur (2000)
Affected-sib-pair analyses reveal support of prior evidence for a susceptibility locus for bipolar disorder, on 21q.
S. Detera-Wadleigh (1996)
10.1073/pnas.1000730107
Phosphodiesterase 11A in brain is enriched in ventral hippocampus and deletion causes psychiatric disease-related phenotypes
M. P. Kelly (2010)
10.1111/j.1460-9568.2005.04321.x
Differential expression and regulation of the cAMP‐selective phosphodiesterase type 4A splice variants in rat brain by chronic antidepressant administration
C. D'Sa (2005)
10.1007/s00213-007-1014-6
Behavioral and neurochemical characterization of mice deficient in the phosphodiesterase-4B (PDE4B) enzyme
J. Siuciak (2007)
10.1073/pnas.87.1.288
Identification of a noncatalytic cGMP-binding domain conserved in both the cGMP-stimulated and photoreceptor cyclic nucleotide phosphodiesterases.
H. Charbonneau (1990)
10.1016/S0898-6568(97)00046-6
Identification and characterisation of a human calmodulin-stimulated phosphodiesterase PDE1B1.
J. Yu (1997)
10.1016/j.bmc.2009.08.041
A new therapeutic approach in Parkinson's disease: some novel quinazoline derivatives as dual selective phosphodiesterase 1 inhibitors and anti-inflammatory agents.
S. Laddha (2009)
10.1038/ng1809
A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia
A. Horvath (2006)
10.1016/j.brainres.2005.02.023
Phosphodiesterase 4B (PDE4B) and cAMP-level regulation within different tissue fractions of rat hippocampal slices during long-term potentiation in vitro
T. Ahmed (2005)
10.1042/BJ3610211
Novel alternative splice variants of rat phosphodiesterase 7B showing unique tissue-specific expression and phosphorylation.
T. Sasaki (2002)
10.1038/ng1006-1091
Many hypotheses but no replication for the association between PDE4D and stroke
J. Rosand (2006)
10.1016/S0006-8993(01)03023-2
Localization of phosphodiesterase-4 isoforms in the medulla and nodose ganglion of the squirrel monkey
S. Lamontagne (2001)
10.1016/S0167-4889(01)00086-6
Expression of cGMP-binding cGMP-specific phosphodiesterase (PDE5) in mouse tissues and cell lines using an antibody against the enzyme amino-terminal domain.
D. Giordano (2001)
10.1007/BF00432761
Characteristic behavioral alterations in rats induced by rolipram and other selective adenosine cyclic 3′,5′-monophosphate phosphodiesterase inhibitors
Helmut Wachtel (2004)
10.1074/jbc.M108353200
TAPAS-1, a Novel Microdomain within the Unique N-terminal Region of the PDE4A1 cAMP-specific Phosphodiesterase That Allows Rapid, Ca2+-triggered Membrane Association with Selectivity for Interaction with Phosphatidic Acid*
G. Baillie (2002)
10.1074/jbc.274.15.10557
Phosphorylation-mediated Activation and Translocation of the Cyclic AMP-specific Phosphodiesterase PDE4D3 by Cyclic AMP-dependent Protein Kinase and Mitogen-activated Protein Kinases
H. Liu (1999)
10.1016/J.JMB.2007.05.060
The molecular basis for different recognition of substrates by phosphodiesterase families 4 and 10.
H. Wang (2007)
10.1038/nbt.1598
Design of phosphodiesterase 4D (PDE4D) allosteric modulators for enhancing cognition with improved safety
A. Burgin (2010)
10.1016/J.EJPHAR.2007.02.008
Sildenafil citrate attenuates a complex maze impairment induced by intracerebroventricular infusion of the NOS inhibitor Nomega-nitro-L-arginine methyl ester.
B. Devan (2007)
10.1124/jpet.108.146332
Inhibition of Phosphodiesterase 10A Increases the Responsiveness of Striatal Projection Neurons to Cortical Stimulation
S. Threlfell (2009)
10.1016/j.neuropharm.2006.04.013
Inhibition of the striatum-enriched phosphodiesterase PDE10A: A novel approach to the treatment of psychosis
J. Siuciak (2006)
10.1038/npp.2009.24
Phosphodiesterase Inhibitors Enhance Object Memory Independent of Cerebral Blood Flow and Glucose Utilization in Rats
K. Rutten (2009)
10.1146/annurev.bi.44.070175.002423
Role of cyclic nucleotides in growth control.
I. Pastan (1975)
10.1021/bi801487x
Kinetic and structural studies of phosphodiesterase-8A and implication on the inhibitor selectivity.
H. Wang (2008)
10.3109/01677063.2011.630494
The Selective Phosphodiesterase 9 (PDE9) Inhibitor PF-04447943 Attenuates a Scopolamine-Induced Deficit in a Novel Rodent Attention Task
Joshua D. Vardigan (2011)
10.1073/pnas.192374899
The two GAF domains in phosphodiesterase 2A have distinct roles in dimerization and in cGMP binding
S. E. Martínez (2002)
10.1016/0306-4522(95)00520-X
Differential cellular pattern of gene expression for two distinct cGMP-inhibited cyclic nucleotide phosphodiesterases in developing and mature rat brain
R. R. Reinhardt (1996)
10.1016/j.neuron.2010.01.014
PKA Dynamics in a Drosophila Learning Center: Coincidence Detection by Rutabaga Adenylyl Cyclase and Spatial Regulation by Dunce Phosphodiesterase
N. Gervasi (2010)
10.1074/JBC.M208456200
The GAFa Domains of Rod cGMP-phosphodiesterase 6 Determine the Selectivity of the Enzyme Dimerization*
K. G. Muradov (2003)
10.1074/JBC.M504398200
Multiple Elements Jointly Determine Inhibitor Selectivity of Cyclic Nucleotide Phosphodiesterases 4 and 7*
H. Wang (2005)
10.1046/J.1432-1327.1999.00963.X
Striatum- and testis-specific phosphodiesterase PDE10A isolation and characterization of a rat PDE10A.
K. Fujishige (1999)
10.1021/bi00778a018
Multiple cyclic nucleotide phosphodiesterase activities from rat brain.
Thompson Wj (1971)
10.1016/S0028-3908(02)00220-4
Regulation of cAMP phosphodiesterase mRNAs expression in rat brain by acute and chronic fluoxetine treatment. An in situ hybridization study
X. Miró (2002)
10.1042/BJ20101184
Phosphorylation of cAMP-specific PDE4A5 (phosphodiesterase-4A5) by MK2 (MAPKAPK2) attenuates its activation through protein kinase A phosphorylation.
Kirsty F Mackenzie (2011)
10.1016/S0898-6568(01)00142-5
Identification of substrate specificity determinants in human cAMP-specific phosphodiesterase 4A by single-point mutagenesis.
W. Richter (2001)
Purification and characterization of cyclic GMP-stimulated cyclic nucleotide phosphodiesterase from calf liver. Effects of divalent cations on activity.
T. Yamamoto (1983)
10.1074/jbc.M511468200
cAMP Is a Ligand for the Tandem GAF Domain of Human Phosphodiesterase 10 and cGMP for the Tandem GAF Domain of Phosphodiesterase 11*
Marco Gross-Langenhoff (2006)
10.1002/ajmg.b.30852
Gene expression and association analyses of the phosphodiesterase 4B (PDE4B) gene in major depressive disorder in the Japanese population
S. Numata (2009)
10.1016/S0378-1119(03)00733-9
Identification and characterization of a new human type 9 cGMP-specific phosphodiesterase splice variant (PDE9A5). Differential tissue distribution and subcellular localization of PDE9A variants.
P. Wang (2003)
10.2210/PDB2HD1/PDB
Crystal structure of phosphodiesterase 9 shows orientation variation of inhibitor IBMX binding
Q. Huai (2004)
10.1016/j.biopsych.2009.01.014
Association Between Genes of Disrupted in Schizophrenia 1 (DISC1) Interactors and Schizophrenia Supports the Role of the DISC1 Pathway in the Etiology of Major Mental Illnesses
L. Tomppo (2009)
10.1124/jpet.107.122218
PDE4B5, a Novel, Super-Short, Brain-Specific cAMP Phosphodiesterase-4 Variant Whose Isoform-Specifying N-Terminal Region Is Identical to That of cAMP Phosphodiesterase-4D6 (PDE4D6)
Y. Cheung (2007)
10.1523/JNEUROSCI.23-16-06452.2003
Individual Cerebellar Purkinje Cells Express Different cGMP Phosphodiesterases (PDEs): In Vivo Phosphorylation of cGMP-Specific PDE (PDE5) as an Indicator of cGMP-dependent protein kinase (PKG) Activation
M. Shimizu-Albergine (2003)
10.1038/ng1245
The gene encoding phosphodiesterase 4D confers risk of ischemic stroke
S. Grétarsdóttir (2003)
10.1016/0306-4522(93)90364-L
A cyclic GMP-stimulated cyclic nucleotide phosphodiesterase gene is highly expressed in the limbic system of the rat brain
D. Repaske (1993)
10.1016/j.pbb.2004.09.019
Phosphodiesterase inhibition by sildenafil citrate attenuates the learning impairment induced by blockade of cholinergic muscarinic receptors in rats
B. Devan (2004)
10.1016/0378-1119(94)90155-4
Differential CNS expression of alternative mRNA isoforms of the mammalian genes encoding cAMP-specific phosphodiesterases.
G. B. Bolger (1994)
10.1016/j.cellsig.2013.10.007
Select 3',5'-cyclic nucleotide phosphodiesterases exhibit altered expression in the aged rodent brain.
M. P. Kelly (2014)
10.1073/PNAS.200355397
Cloning and characterization of two splice variants of human phosphodiesterase 11A.
J. M. Hetman (2000)
Phosphorylation results in activation of a cAMP phosphodiesterase in human platelets.
C. Macphee (1988)
10.1097/WNR.0b013e3282f16dca
Expression of phosphodiesterase 4 is altered in the brains of subjects with autism
Natalie N. Braun (2007)
10.1161/CIRCGENETICS.108.833806
A Genome-Wide Association Scan of RR and QT Interval Duration in 3 European Genetically Isolated Populations: The EUROSPAN Project
F. Marroni (2009)
10.1016/S0969-2126(03)00123-0
Three-dimensional structures of PDE4D in complex with roliprams and implication on inhibitor selectivity.
Q. Huai (2003)
10.1523/JNEUROSCI.2518-08.2008
Distinct Roles of PDE4 and PDE10A in the Regulation of cAMP/PKA Signaling in the Striatum
A. Nishi (2008)
10.1016/j.cellsig.2008.09.017
Ndel1 alters its conformation by sequestering cAMP-specific phosphodiesterase-4D3 (PDE4D3) in a manner that is dynamically regulated through Protein Kinase A (PKA).
D. M. Collins (2008)
10.1073/pnas.82.9.2603
Differential regulation of bovine brain calmodulin-dependent cyclic nucleotide phosphodiesterase isoenzymes by cyclic AMP-dependent protein kinase and calmodulin-dependent phosphatase.
R. Sharma (1985)
In vivo differential prenylation of retinal cyclic GMP phosphodiesterase catalytic subunits.
J. Anant (1992)
10.1016/j.neuint.2004.03.022
Phosphodiesterase type 5 inhibition improves early memory consolidation of object information
J. Prickaerts (2004)
10.1038/sj.ijir.3901317
3′,5′-Cyclic nucleotide phosphodiesterase 11A: localization in human tissues
K. Loughney (2005)
10.1073/pnas.0907635106
Mechanism for the allosteric regulation of phosphodiesterase 2A deduced from the X-ray structure of a near full-length construct
J. Pandit (2009)
10.1016/S0378-1119(03)00809-6
Molecular comparison of rat cyclic nucleotide phosphodiesterase 8 family: unique expression of PDE8B in rat brain.
Tamaki Kobayashi (2003)
10.1085/JGP.118.1.63
In Vivo Assessment of Local Phosphodiesterase Activity Using Tailored Cyclic Nucleotide–Gated Channels as Camp Sensors
T. C. Rich (2001)
10.1016/S0079-6123(09)17908-6
Differential function of phosphodiesterase families in the brain: gaining insights through the use of genetically modified animals.
M. P. Kelly (2009)
10.1007/s000180050364
Calmodulin-dependent cyclic nucleotide phosphodiesterase (PDE1)
R. Kakkar (1999)
Purification and characterization of a cyclic GMP-stimulated cyclic nucleotide phosphodiesterase from bovine tissues.
T. J. Martins (1982)
10.1074/jbc.M800230200
Functional Chimeras of the Phosphodiesterase 5 and 10 Tandem GAF Domains*
Karina Hofbauer (2008)
10.1016/j.neuropharm.2008.07.005
The novel selective PDE9 inhibitor BAY 73-6691 improves learning and memory in rodents
F. V. D. Staay (2008)
10.1038/nature01914
Structure of the catalytic domain of human phosphodiesterase 5 with bound drug molecules
Byung-Je Sung (2003)
10.1007/s004390050838
Identification and characterization of a novel cyclic nucleotide phosphodiesterase gene (PDE9A) that maps to 21q22.3: alternative splicing of mRNA transcripts, genomic structure and sequence
M. Guipponi (1998)
10.1046/j.1471-4159.2001.00407.x
Expression and role of phosphodiesterase 6 in the chicken pineal gland
F. Morin (2001)
10.1074/jbc.M510372200
Phosphodiesterase-5 Gln817 Is Critical for cGMP, Vardenafil, or Sildenafil Affinity
R. Zoraghi (2006)
10.1074/JBC.270.52.30989
Identification of Inhibitory and Calmodulin-binding Domains of the PDE1A1 and PDE1A2 Calmodulin-stimulated Cyclic Nucleotide Phosphodiesterases (*)
W. K. Sonnenburg (1995)
10.1161/01.RES.0000250046.69918.d5
Cyclic AMP Imaging in Adult Cardiac Myocytes Reveals Far-Reaching &bgr;1-Adrenergic but Locally Confined &bgr;2-Adrenergic Receptor–Mediated Signaling
V. Nikolaev (2006)
10.1016/j.jpsychires.2008.01.013
Positive association of the PDE4B (phosphodiesterase 4B) gene with schizophrenia in the Japanese population.
S. Numata (2008)
Molecular cloning of the rat adipocyte hormone-sensitive cyclic GMP-inhibited cyclic nucleotide phosphodiesterase.
M. Taira (1993)
10.1073/pnas.122041599
Induction of the cyclic nucleotide phosphodiesterase PDE4B is essential for LPS-activated TNF-α responses
S-L Catherine Jin (2002)
10.1124/jpet.107.133405
Phosphorylation Increases Affinity of the Phosphodiesterase-5 Catalytic Site for Tadalafil
Emmanuel P. Bessay (2008)
10.1016/S0006-291X(03)00021-4
Identification and distribution of different mRNA variants produced by differential splicing in the human phosphodiesterase 9A gene.
C. Rentero (2003)
10.1074/JBC.M204832200
Cyclic AMP-dependent Transcriptional Up-regulation of Phosphodiesterase 4D5 in Human Airway Smooth Muscle Cells
I. L. Le Jeune (2002)
10.1074/JBC.M312687200
The Oligomerization State Determines Regulatory Properties and Inhibitor Sensitivity of Type 4 cAMP-specific Phosphodiesterases*
W. Richter (2004)
10.1002/(SICI)1096-9861(19990503)407:2<287::AID-CNE9>3.0.CO;2-R
Cyclic AMP phosphodiesterases are localized in regions of the mouse brain associated with reinforcement, movement, and affect
J. Cherry (1999)
10.1210/MEND.11.7.9941
Characterization of an intronic promoter of a cyclic adenosine 3',5'-monophosphate (cAMP)-specific phosphodiesterase gene that confers hormone and cAMP inducibility.
E. Vicini (1997)
10.1016/j.jchemneu.2010.03.004
The human area postrema and other nuclei related to the emetic reflex express cAMP phosphodiesterases 4B and 4D
F. Mori (2010)
10.1074/JBC.275.16.12331
Functions of the N-terminal Region of Cyclic Nucleotide Phosphodiesterase 3 (PDE 3) Isoforms*
Y. Ke-nan (2000)
10.1186/1471-2350-8-S1-S9
Genome-wide association of sleep and circadian phenotypes
D. Gottlieb (2007)
10.1016/S0891-0618(00)00097-1
Phosphodiesterase type 4 isozymes expression in human brain examined by in situ hybridization histochemistry and [3H]rolipram binding autoradiography: Comparison with monkey and rat brain
S. Pérez-Torres (2000)
Analysis of a mutation in phosphodiesterase type 4 that alters both inhibitor activity and nucleotide selectivity.
S. Herman (2000)
Defective RNA splicing resulting from a mutation in the cyclic guanosine monophosphate-phosphodiesterase beta-subunit gene.
N. I. Piriev (1998)
10.1038/NN885
A phosphatidylinositol 3-kinase–phosphodiesterase 3B–cyclic AMP pathway in hypothalamic action of leptin on feeding
A. Zhao (2002)
10.1006/JMBI.2001.4813
Molecular organization of bovine rod cGMP-phosphodiesterase 6.
J. F. Kameni Tcheudji (2001)
Insulin-sensitive phosphodiesterase. Its localization, hormonal stimulation, and oxidative stabilization.
T. Kôno (1975)
10.1042/BJ20090982
Binding of cyclic nucleotides to phosphodiesterase 10A and 11A GAF domains does not stimulate catalytic activity.
Karina Matthiesen (2009)
10.1073/PNAS.93.1.295
cAMP compartmentation is responsible for a local activation of cardiac Ca2+ channels by beta-adrenergic agonists.
J. Jurevičius (1996)
10.1074/jbc.M003041200
Isolation and Characterization of Two Novel Phosphodiesterase PDE11A Variants Showing Unique Structure and Tissue-specific Expression*
K. Yuasa (2000)
10.4049/jimmunol.173.8.4806
A-Kinase Anchoring Proteins Interact with Phosphodiesterases in T Lymphocyte Cell Lines1
Angela L. Asirvatham (2004)
10.1016/j.schres.2008.01.029
PDE4B polymorphisms and decreased PDE4B expression are associated with schizophrenia
S. Fatemi (2008)
10.1523/JNEUROSCI.1493-07.2007
Isoform-Selective Susceptibility of DISC1/Phosphodiesterase-4 Complexes to Dissociation by Elevated Intracellular cAMP Levels
H. Murdoch (2007)
10.1016/0169-328X(94)90107-4
Localization of 63-kDa calmodulin-stimulated phosphodiesterase mRNA in the rat brain by in situ hybridization histochemistry.
T. Furuyama (1994)
10.1016/j.neuroscience.2005.01.050
Neuronal expression of cAMP-specific phosphodiesterase 7B mRNA in the rat brain
E. Reyes-Irisarri (2005)
The short-term activation of a rolipram-sensitive, cAMP-specific phosphodiesterase by thyroid-stimulating hormone in thyroid FRTL-5 cells is mediated by a cAMP-dependent phosphorylation.
C. Sette (1994)
10.1021/bi00238a021
Phosphorylation and characterization of bovine heart calmodulin-dependent phosphodiesterase.
R. Sharma (1991)
10.1021/JA005529A
First computational evidence for a catalytic bridging hydroxide ion in a phosphodiesterase active site.
C. Zhan (2001)
10.1126/SCIENCE.1058040
The Sequence of the Human Genome
J. Venter (2001)
Calmodulin and Ca2+-dependent phosphorylation and dephosphorylation of 63-kDa subunit-containing bovine brain calmodulin-stimulated cyclic nucleotide phosphodiesterase isozyme.
R. Sharma (1986)
10.1073/pnas.0708850105
Structural basis for the catalytic mechanism of human phosphodiesterase 9
S. Liu (2008)
10.1006/bbrc.1994.2886
A novel cyclic GMP stimulated phosphodiesterase from rat brain.
Qinbo Yang (1994)
10.1074/JBC.275.15.10831
Short Term Feedback Regulation of cAMP in FRTL-5 Thyroid Cells
N. Oki (2000)
10.1038/ng.201
Identification of loci associated with schizophrenia by genome-wide association and follow-up
M. O’Donovan (2008)
10.1074/jbc.274.20.13729
Cyclic GMP Phosphodiesterase-5: Target of Sildenafil*
J. Corbin (1999)
10.1023/A:1025704031210
Cloning and localization of the cGMP-specific phosphodiesterase type 9 in the rat brain
W. C. V. van Staveren (2002)
10.1073/PNAS.0401120101
Crystal structure of phosphodiesterase 9 shows orientation variation of inhibitor 3-isobutyl-1-methylxanthine binding.
Q. Huai (2004)
10.1016/J.CELLSIG.2005.04.003
In resting COS1 cells a dominant negative approach shows that specific, anchored PDE4 cAMP phosphodiesterase isoforms gate the activation, by basal cyclic AMP production, of AKAP-tethered protein kinase A type II located in the centrosomal region.
A. McCahill (2005)
10.1073/PNAS.94.7.3388
A subset of olfactory neurons that selectively express cGMP-stimulated phosphodiesterase (PDE2) and guanylyl cyclase-D define a unique olfactory signal transduction pathway.
D. Juilfs (1997)
10.1016/0024-3205(96)00528-0
Inhibition of bovine brain calmodulin-dependent cyclic nucleotide phosphodiesterase isozymes by deprenyl.
R. Kakkar (1996)
10.1016/j.cell.2012.03.028
Sequencing Chromosomal Abnormalities Reveals Neurodevelopmental Loci that Confer Risk across Diagnostic Boundaries
M. Talkowski (2012)
10.1016/j.neuropharm.2006.01.012
Genetic deletion of the striatum-enriched phosphodiesterase PDE10A: Evidence for altered striatal function
J. Siuciak (2006)
10.1073/PNAS.95.15.8991
Cloning and characterization of a cAMP-specific cyclic nucleotide phosphodiesterase.
S. Soderling (1998)
10.1006/BBRC.1999.1013
Characterization and phosphorylation of PDE10A2, a novel alternative splice variant of human phosphodiesterase that hydrolyzes cAMP and cGMP.
J. Kotera (1999)
10.1124/MOL.105.017608
Characterization of the First Potent and Selective PDE9 Inhibitor Using a cGMP Reporter Cell Line
F. Wunder (2005)
Molecular cloning of a cyclic GMP-stimulated cyclic nucleotide phosphodiesterase cDNA. Identification and distribution of isozyme variants.
W. K. Sonnenburg (1991)
10.1210/EN.2006-1420
Daily rhythm in pineal phosphodiesterase (PDE) activity reflects adrenergic/3',5'-cyclic adenosine 5'-monophosphate induction of the PDE4B2 variant.
Jong-So Kim (2007)
10.1021/JP066582+
The Mechanism of Cyclic Nucleotide Hydrolysis in the Phosphodiesterase Catalytic Site
E. Salter (2007)
10.1016/j.neuroscience.2004.01.005
Regulation of the phosphodiesterase PDE4B3-ISOTYPE during long-term potentiation in the area dentata in vivo
T. Ahmed (2004)
10.1124/JPET.302.1.249
Hydrolysis of N-methyl-D-aspartate receptor-stimulated cAMP and cGMP by PDE4 and PDE2 phosphodiesterases in primary neuronal cultures of rat cerebral cortex and hippocampus.
Neesha U. Suvarna (2002)
10.1046/j.1471-4159.2002.00903.x
Reciprocal regulation of calcium dependent and calcium independent cyclic AMP hydrolysis by protein phosphorylation
Kok-Long Ang (2002)
10.1042/BJ20071251
Human PDE4A8, a novel brain-expressed PDE4 cAMP-specific phosphodiesterase that has undergone rapid evolutionary change.
Kirsty F Mackenzie (2008)
10.1073/pnas.87.2.533
Evidence that insulin and isoprenaline activate the cGMP-inhibited low-Km cAMP phosphodiesterase in rat fat cells by phosphorylation.
E. Degerman (1990)
10.1042/BJ20050030
Splice variants of the cyclic nucleotide phosphodiesterase PDE4D are differentially expressed and regulated in rat tissue.
W. Richter (2005)
10.1016/S0893-133X(02)00344-5
Antidepressant-like Profile and Reduced Sensitivity to Rolipram in Mice Deficient in the PDE4D Phosphodiesterase Enzyme
Han-ting Zhang (2002)
10.1124/MOL.51.2.242
Selective activation of rolipram-sensitive, cAMP-specific phosphodiesterase isoforms by phosphatidic acid.
G. Némoz (1997)
10.1007/s00213-008-1278-5
A placebo-controlled study of sildenafil effects on cognition in schizophrenia
D. Goff (2008)
10.1007/s003359900820
Genomic structure and chromosome location of the murine PDE1B phosphodiesterase gene
T. Reed (1998)
10.1016/j.euroneuro.2007.08.002
Phosphodiesterase 10A inhibition is associated with locomotor and cognitive deficits and increased anxiety in mice
A. Hebb (2008)
10.1161/01.STR.0000176497.94458.27
Comment on the phosphodiesterase 4D replication study by Bevan et al.
S. Grétarsdóttir (2005)
10.1016/j.neuropharm.2011.05.009
The selective phosphodiesterase 9 (PDE9) inhibitor PF-04447943 (6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one) enhances synaptic plasticity and cognitive function in rodents
P. H. Hutson (2011)
10.1016/S0306-4522(02)00838-2
Expression of the specific type IV phosphodiesterase gene PDE4B3 during different phases of long-term potentiation in single hippocampal slices of rats in vitro
T. Ahmed (2003)
Activation and selective inhibition of a cyclic AMP-specific phosphodiesterase, PDE-4D3.
R. Álvarez (1995)
10.1038/ng0594-64
Heterozygous missense mutation in the rod cGMP phosphodiesterase β–subunit gene in autosomal dominant stationary night blindness
A. Gal (1994)
10.1016/S0006-8993(96)01318-2
Amantadine: an antiparkinsonian agent inhibits bovine brain 60kDa calmodulin-dependent cyclic nucleotide phosphodiesterase isozyme
R. Kakkar (1997)
10.1074/jbc.M600595200
The Inhibitory γ Subunit of the Rod cGMP Phosphodiesterase Binds the Catalytic Subunits in an Extended Linear Structure*
L. Guo (2006)
10.1172/JCI15506
Deletion of phosphodiesterase 4D in mice shortens alpha(2)-adrenoceptor-mediated anesthesia, a behavioral correlate of emesis.
A. Robichaud (2002)
10.1073/pnas.86.21.8197
The mRNA encoding a high-affinity cAMP phosphodiesterase is regulated by hormones and cAMP.
J. Swinnen (1989)
10.2165/0023210-200822120-00002
The Role of Phosphodiesterases in Schizophrenia
J. Siuciak (2008)
10.1016/S1047-8477(02)00502-6
Three-dimensional structure of non-activated cGMP phosphodiesterase 6 and comparison of its image with those of activated forms.
N. Kajimura (2002)
10.1074/JBC.274.49.34613
Expression of an Active, Monomeric Catalytic Domain of the cGMP-binding cGMP-specific Phosphodiesterase (PDE5)*
T. L. Fink (1999)
10.1124/jpet.111.191353
Phosphodiesterase 9A Regulates Central cGMP and Modulates Responses to Cholinergic and Monoaminergic Perturbation In Vivo
R. Kleiman (2012)
10.1038/emm.2000.19
Differential changes in the expression of cyclic nucleotide phosphodiesterase isoforms in rat brains by chronic treatment with electroconvulsive shock
C. H. Cho (2000)
10.1038/sj.ijir.3901441
Phosphodiesterase 11: a brief review of structure, expression and function
A. Makhlouf (2006)
10.1529/BIOPHYSJ.106.086835
Characterization of a catalytic ligand bridging metal ions in phosphodiesterases 4 and 5 by molecular dynamics simulations and hybrid quantum mechanical/molecular mechanical calculations.
Y. Xiong (2006)
10.1016/S0898-6568(01)00150-4
Identification of inhibitor binding sites of the cAMP-specific phosphodiesterase 4.
W. Richter (2001)
10.1523/JNEUROSCI.21-22-09068.2001
Expression of cGMP-Specific Phosphodiesterase 9A mRNA in the Rat Brain
S. Andreeva (2001)
10.1073/pnas.0907720106
A homologous genetic basis of the murine cpfl1 mutant and human achromatopsia linked to mutations in the PDE6C gene
B. Chang (2009)
10.1016/j.neuropharm.2004.07.040
Inhibition of phosphodiesterase 2 increases neuronal cGMP, synaptic plasticity and memory performance
F. Boess (2004)
10.1111/j.0953-816X.2004.03327.x
Species differences in the localization of cGMP‐producing and NO‐responsive elements in the mouse and rat hippocampus using cGMP immunocytochemistry
W. C. V. van Staveren (2004)
Demonstration of bovine brain calmodulin-dependent cyclic nucleotide phosphodiesterase isozymes by monoclonal antibodies.
R. Sharma (1984)
10.1126/SCIENCE.1069982
Discrete Microdomains with High Concentration of cAMP in Stimulated Rat Neonatal Cardiac Myocytes
M. Zaccolo (2002)
10.1016/0165-3806(90)90015-Q
Developmental expression of calmodulin-dependent cyclic nucleotide phosphodiesterase in rat brain.
M. Billingsley (1990)
10.1146/ANNUREV.PHARMTOX.41.1.751
Compartmentation of G protein-coupled signaling pathways in cardiac myocytes.
S. Steinberg (2001)
10.1124/pr.58.3.5
Cyclic Nucleotide Phosphodiesterases: Molecular Regulation to Clinical Use
A. Bender (2006)
10.1073/pnas.0700279104
Structural insight into substrate specificity of phosphodiesterase 10
H. Wang (2007)
10.1111/j.1471-4159.2007.05152.x
Increased social interaction in mice deficient of the striatal medium spiny neuron‐specific phosphodiesterase 10A2
H. Sano (2008)
10.1073/pnas.221381398
A uniform extracellular stimulus triggers distinct cAMP signals in different compartments of a simple cell
T. C. Rich (2001)
10.1016/j.nbd.2009.02.014
Phosphodiesterase 10 inhibition reduces striatal excitotoxicity in the quinolinic acid model of Huntington's disease
C. Giampà (2009)
10.1074/jbc.271.41.25699
The Calmodulin-dependent Phosphodiesterase Gene PDE1C Encodes Several Functionally Different Splice Variants in a Tissue-specific Manner*
C. Yan (1996)
10.1074/jbc.M803306200
Critical Role of PDE4D in β2-Adrenoceptor-dependent cAMP Signaling in Mouse Embryonic Fibroblasts*
M. D. Bruss (2008)
10.1074/jbc.M203585200
Dimerization of the Type 4 cAMP-specific Phosphodiesterases Is Mediated by the Upstream Conserved Regions (UCRs)*
W. Richter (2002)
10.1093/emboj/20.8.1921
mAKAP assembles a protein kinase A/PDE4 phosphodiesterase cAMP signaling module
K. Dodge (2001)
10.1093/emboj/18.4.893
The MAP kinase ERK2 inhibits the cyclic AMP‐specific phosphodiesterase HSPDE4D3 by phosphorylating it at Ser579
R. Hoffmann (1999)
10.1016/j.ajhg.2009.04.006
Genome-wide association analysis identifies PDE4D as an asthma-susceptibility gene.
B. Himes (2009)
10.1074/JBC.M407521200
Phosphodiesterase 4D Forms a cAMP Diffusion Barrier at the Apical Membrane of the Airway Epithelium*
A. P. Barnes (2005)
10.1021/BI049868I
Crystal structure of human phosphodiesterase 3B: atomic basis for substrate and inhibitor specificity.
G. Scapin (2004)
10.1074/JBC.C000911200
Phosphodiesterase 4D and Protein Kinase A Type II Constitute a Signaling Unit in the Centrosomal Area*
K. Taskén (2001)
10.1038/sj.npp.1301537
Anxiogenic-Like Behavioral Phenotype of Mice Deficient in Phosphodiesterase 4B (PDE4B)
Han-ting Zhang (2008)
10.1016/S0167-4781(00)00293-1
Human Ca2+/calmodulin-dependent phosphodiesterase PDE1A: novel splice variants, their specific expression, genomic organization, and chromosomal localization.
H. Michibata (2001)
10.1023/A:1020975913007
Immunohistochemical Localization of Calmodulin-Dependent Cyclic Phosphodiesterase in the Human Brain
S. Lal (2004)
10.1042/BJ3330139
cAMP-specific phosphodiesterase HSPDE4D3 mutants which mimic activation and changes in rolipram inhibition triggered by protein kinase A phosphorylation of Ser-54: generation of a molecular model.
R. Hoffmann (1998)
10.1016/j.bbr.2005.04.021
The selective PDE5 inhibitor, sildenafil, improves object memory in Swiss mice and increases cGMP Levels in hippocampal slices
K. Rutten (2005)
10.1124/jpet.109.156919
Phosphodiesterase 5A Inhibitors Improve Functional Recovery after Stroke in Rats: Optimized Dosing Regimen with Implications for Mechanism
F. Menniti (2009)
10.1074/jbc.271.28.16526
Phosphorylation and Activation of a cAMP-specific Phosphodiesterase by the cAMP-dependent Protein Kinase
C. Sette (1996)
10.1007/s00213-007-0999-1
Selective PDE inhibitors rolipram and sildenafil improve object retrieval performance in adult cynomolgus macaques
K. Rutten (2007)
10.1523/JNEUROSCI.14-03-01251.1994
Expression of a calmodulin-dependent phosphodiesterase isoform (PDE1B1) correlates with brain regions having extensive dopaminergic innervation
J. W. Polli (1994)
10.1042/bj3060801
Identification and characterization of the type-IVA cyclic AMP-specific phosphodiesterase RD1 as a membrane-bound protein expressed in cerebellum.
Y. Shakur (1995)
10.1097/YPG.0b013e328014492b
The PDE4B gene confers sex-specific protection against schizophrenia
B. Pickard (2007)
10.1007/PL00007092
Central effects of sildenafil (Viagra) on auditory selective attention and verbal recognition memory in humans: a study with event-related brain potentials
D. Schultheiss (2001)
10.1083/jcb.200605050
PGE1 stimulation of HEK293 cells generates multiple contiguous domains with different [cAMP]: role of compartmentalized phosphodiesterases
A. Terrin (2006)
10.1038/ng1194-291
A possible vulnerability locus for bipolar affective disorder on chromosome 21q22.3
R. Straub (1994)
10.1126/science.1112915
DISC1 and PDE4B Are Interacting Genetic Factors in Schizophrenia That Regulate cAMP Signaling
J. Millar (2005)
10.1073/pnas.0602795103
Phosphodiesterase genes are associated with susceptibility to major depression and antidepressant treatment response
M. Wong (2006)
10.1093/emboj/cdg051
PDE5 is converted to an activated state upon cGMP binding to the GAF A domain
S. Rybalkin (2003)
10.1023/A:1017573722074
Sildenafil (Viagra®): Is there an influence on psychological performance?
H. Grass (2004)
10.1124/jpet.109.155994
Phosphodiesterase 10A Inhibitor Activity in Preclinical Models of the Positive, Cognitive, and Negative Symptoms of Schizophrenia
Steven M. Grauer (2009)
10.1016/J.MOLCEL.2004.07.005
A glutamine switch mechanism for nucleotide selectivity by phosphodiesterases.
K. Y. Zhang (2004)
10.1139/o86-142
Regulation of cAMP concentration by calmodulin-dependent cyclic nucleotide phosphodiesterase.
R. Sharma (1986)
10.1016/0014-5793(93)81536-9
Characterization of 3':5' cyclic nucleotide phosphodiesterase activities of mouse neuroblastoma N18TG2 cells
M. Giorgi (1993)
Differential recognition of calmodulin-enzyme complexes by a conformation-specific anti-calmodulin monoclonal antibody.
R. S. Hansen (1986)
10.1038/sj.bjp.0704743
Long PDE4 cAMP specific phosphodiesterases are activated by protein kinase A‐mediated phosphorylation of a single serine residue in Upstream Conserved Region 1 (UCR1)
Simon J MacKenzie (2002)
10.1002/jnr.21788
In vivo effects of phosphodiesterase inhibition on basal cyclic guanosine monophosphate levels in the prefrontal cortex, hippocampus and cerebellum of freely moving rats
A. Marte (2008)
10.1523/JNEUROSCI.23-37-11770.2003
Neurotrophins Elevate cAMP to Reach a Threshold Required to Overcome Inhibition by MAG through Extracellular Signal-Regulated Kinase-Dependent Inhibition of Phosphodiesterase
Y. Gao (2003)
10.1046/J.1432-1327.2001.02366.X
Identification of rat cyclic nucleotide phosphodiesterase 11A (PDE11A): comparison of rat and human PDE11A splicing variants.
K. Yuasa (2001)
10.1038/nature03966
The protein kinase A anchoring protein mAKAP coordinates two integrated cAMP effector pathways
K. Dodge-Kafka (2005)
10.1074/jbc.M606936200
Protein Kinase A Phosphorylation of Human Phosphodiesterase 3B Promotes 14-3-3 Protein Binding and Inhibits Phosphatase-catalyzed Inactivation*
D. Palmer (2007)
10.1016/j.schres.2009.06.019
Genetic association and post-mortem brain mRNA analysis of DISC1 and related genes in schizophrenia
A. Rastogi (2009)
10.1016/S0014-4886(03)00042-6
Alterations on phosphodiesterase type 7 and 8 isozyme mRNA expression in Alzheimer’s disease brains examined by in situ hybridization
S. Pérez-Torres (2003)
10.1016/j.neuropharm.2007.12.002
Chronic haloperidol and clozapine produce different patterns of effects on phosphodiesterase-1B, -4B, and -10A expression in rat striatum
D. Dlaboga (2008)
10.1055/s-2007-1017435
Results of a phase II study of the antidepressant effect of rolipram.
E. Zeller (1984)
10.1101/gad.7.7b.1447
Genetic dissection of the learning/memory gene dunce of Drosophila melanogaster.
Y. Qiu (1993)
10.1146/ANNUREV.BIOCHEM.76.060305.150444
Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling.
M. Conti (2007)
10.1002/SYN.10100
Differential distribution of PDE4D splice variant mRNAs in rat brain suggests association with specific pathways and presynaptical localization.
X. Miró (2002)
10.1111/j.1460-9568.2007.05589.x
Expression of the cGMP‐specific phosphodiesterases 2 and 9 in normal and Alzheimer's disease human brains
Elisabet Reyes-Irisarri (2007)
10.1074/JBC.274.28.19677
Activation of the cAMP-specific Phosphodiesterase PDE4D3 by Phosphorylation
J. Lim (1999)
10.1016/S0378-1119(99)00171-7
Isolation and characterization of PDE10A, a novel human 3', 5'-cyclic nucleotide phosphodiesterase.
K. Loughney (1999)
10.1111/j.1471-4159.2004.02354.x
Transcriptional activation of phosphodiesterase 7B1 by dopamine D1 receptor stimulation through the cyclic AMP/cyclic AMP‐dependent protein kinase/cyclic AMP‐response element binding protein pathway in primary striatal neurons
T. Sasaki (2004)
10.1523/JNEUROSCI.14-03-00973.1994
Differential expression of the 61 kDa and 63 kDa calmodulin-dependent phosphodiesterases in the mouse brain
C. Yan (1994)
10.1006/PREP.2000.1260
Refolding, purification, and characterization of human recombinant PDE4A constructs expressed in Escherichia coli.
W. Richter (2000)
Multiple cyclic nucleotide phosphodiesterases.
J. Beavo (1994)
10.1016/0022-2836(91)90496-S
Characterization of the memory gene dunce of Drosophila melanogaster.
Y. Qiu (1991)
10.1126/SCIENCE.288.5472.1822
Atomic structure of PDE4: insights into phosphodiesterase mechanism and specificity.
R. Xu (2000)
10.1073/PNAS.96.12.7071
Isolation and characterization of a dual-substrate phosphodiesterase gene family: PDE10A.
S. Soderling (1999)
10.1016/S0378-1119(98)00303-5
Isolation and characterization of cDNAs encoding PDE5A, a human cGMP-binding, cGMP-specific 3',5'-cyclic nucleotide phosphodiesterase.
K. Loughney (1998)
Regulation of cyclic nucleotide phosphodiesterases in cultured hepatoma cells by dexamethasone and N6,O2'-dibutyryl adenosine 3':k'-monophosphate.
P. Ross (1977)
Mapping the functional domains of human recombinant phosphodiesterase 4A: structural requirements for catalytic activity and rolipram binding.
S. Jacobitz (1996)
10.1038/emboj.2009.284
Structural basis of phosphodiesterase 6 inhibition by the C‐terminal region of the γ‐subunit
Brandy Barren (2009)
10.1016/j.brainres.2008.02.108
The effect of selective inhibition of cyclic GMP hydrolyzing phosphodiesterases 2 and 5 on learning and memory processes and nitric oxide synthase activity in brain during aging
K. Domek-Łopacińska (2008)
10.1097/nen.0b013e3181567c31
Selective Induction of cAMP Phosphodiesterase PDE4B2 Expression in Experimental Autoimmune Encephalomyelitis
Elisabet Reyes-Irisarri (2007)
10.1016/j.tibs.2009.09.007
Underpinning compartmentalised cAMP signalling through targeted cAMP breakdown.
M. Houslay (2010)
10.1021/BI7009629
N-Terminal domain of phosphodiesterase-11A4 (PDE11A4) decreases affinity of the catalytic site for substrates and tadalafil, and is involved in oligomerization.
J. L. Weeks (2007)
10.1016/j.neuroscience.2005.12.042
Cellular and subcellular localization of PDE10A, a striatum-enriched phosphodiesterase
Z. Xie (2006)
10.1073/PNAS.92.21.9677
Molecular cloning and characterization of a calmodulin-dependent phosphodiesterase enriched in olfactory sensory neurons.
C. Yan (1995)
10.1038/NG1295-468
Autosomal recessive retinitis pigmentosa caused by mutations in the α subunit of rod cGMP phosphodiesterase
S. H. Huang (1995)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar